Predicting drug-resistant infections through hospital wastewater
Part of Infections clinical trials.
This study looks at hospital wastewater to predict outbreaks of antibiotic-resistant bacteria. To take part, you must have a confirmed infection from such bacteria while in one of four specific hospital areas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a patient in one of four specific hospital buildings: Outpatient, Internal Medicine, Surgery, or Emergency/Fever Clinic.
- You must have a confirmed infection caused by bacteria that are resistant to common antibiotics (carbapenem-resistant).
- The infection must be active, not just bacteria present without causing illness (colonization).
- Your infection details (type of bacteria, sample source, date, and location) must be fully recorded.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at wastewater from a hospital to track antibiotic-resistant bacteria. By analyzing these samples, researchers hope to create an early warning system to improve infection control and protect patients.
This trial looks at antibiotic resistance by testing wastewater in nursing homes. It aims to understand how resistance spreads and how to better protect residents.
This study looks at new ways to fight antibiotic-resistant bacteria in people with certain common infections. It may help by testing approaches tailored to the specific germs found in your urine, lungs, or deeper infections.
This study collects and studies lab-detected germs in hospital patients that produce special enzymes making some antibiotics less effective. It helps researchers understand how these resistant germs spread over time in Switzerland.
This study validates a prediction tool designed to identify which ICU patients are at risk of developing multidrug-resistant gram-negative bacteria (a serious infection resistant to many antibiotics). The tool may help doctors start appropriate treatment earlier and improve patient outcomes.
This study looks at how Klebsiella pneumoniae bacteria that are resistant to many antibiotics form a protective layer (biofilm) and pump out drugs (efflux pump activity). By understanding these mechanisms, doctors may find better ways to treat these tough infections.
Hear when a new Drug Resistance, Bacterial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.